These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 8666978)
1. Gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. Taga T J Neurochem; 1996 Jul; 67(1):1-10. PubMed ID: 8666978 [TBL] [Abstract][Full Text] [Related]
2. The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Taga T Ann Med; 1997 Feb; 29(1):63-72. PubMed ID: 9073325 [TBL] [Abstract][Full Text] [Related]
3. Gp130 and the interleukin-6 family of cytokines. Taga T; Kishimoto T Annu Rev Immunol; 1997; 15():797-819. PubMed ID: 9143707 [TBL] [Abstract][Full Text] [Related]
4. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities. Nakashima K; Taga T Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167 [TBL] [Abstract][Full Text] [Related]
5. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280 [TBL] [Abstract][Full Text] [Related]
8. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570 [TBL] [Abstract][Full Text] [Related]
9. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
10. Signaling mechanisms through gp130: a model of the cytokine system. Hirano T; Nakajima K; Hibi M Cytokine Growth Factor Rev; 1997 Dec; 8(4):241-52. PubMed ID: 9620640 [TBL] [Abstract][Full Text] [Related]
11. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305 [TBL] [Abstract][Full Text] [Related]
12. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404 [TBL] [Abstract][Full Text] [Related]
14. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380 [TBL] [Abstract][Full Text] [Related]
15. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Matsuda T; Takahashi-Tezuka M; Fukada T; Okuyama Y; Fujitani Y; Tsukada S; Mano H; Hirai H; Witte ON; Hirano T Blood; 1995 Feb; 85(3):627-33. PubMed ID: 7530500 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Hirano T; Matsuda T; Nakajima K Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593 [TBL] [Abstract][Full Text] [Related]
17. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830 [TBL] [Abstract][Full Text] [Related]
18. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Taga T; Kishimoto T Curr Opin Immunol; 1995 Feb; 7(1):17-23. PubMed ID: 7772277 [TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Yoshida K; Taga T; Saito M; Suematsu S; Kumanogoh A; Tanaka T; Fujiwara H; Hirata M; Yamagami T; Nakahata T; Hirabayashi T; Yoneda Y; Tanaka K; Wang WZ; Mori C; Shiota K; Yoshida N; Kishimoto T Proc Natl Acad Sci U S A; 1996 Jan; 93(1):407-11. PubMed ID: 8552649 [TBL] [Abstract][Full Text] [Related]
20. Signal transduction through homo- or heterodimers of gp130. Kishimoto T Stem Cells; 1994; 12 Suppl 1():37-44; discussion 44-5. PubMed ID: 7696968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]